What is the Accretion Pharmaceuticals Ltd share price today?

The share price of NSE:ACCPL-ST on 01 Oct 2026 (as of 15:02:56 IST) is ₹203.3.

What is the NSE:ACCPL-ST 52 week high low price?

Over the past 52 weeks (as of 01 Oct 2026), the NSE:ACCPL-ST 52 week high low range shows a high of ₹220 and a low of ₹53.8.

What is the Accretion Pharmaceuticals Ltd market cap?

As on 01 Oct 2026, Accretion Pharmaceuticals Ltd market cap is ₹2378820000.

What is the shareholding pattern of Accretion Pharmaceuticals Ltd Stock?

The shareholding pattern of Accretion Pharmaceuticals Ltd, as of last reported-on 30 Jun 2026 is: Promoters: 73.52% Foreign Institutional Investors (FII): 0% Domestic Institutional Investors (DII): 2.76% Mutual Funds: 0% Retail & Others: 23.72% This demonstrates an outstanding distribution of ownership.

What are the PE and PB ratios of Accretion Pharmaceuticals Ltd?

The Price-to-Earnings (PE) ratio of Accretion Pharmaceuticals Ltd is 24.6064, and the Price-to-Book (PB) ratio is 1.3548, as on 01 Oct 2026.

Accretion Pharmaceuticals Share Price

193.20+0.00 (+0.00%)

+229.13% past 1 Year

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Login to analyze with FIA

1 Day

+0.00%

1 Week

+2.25%

1 Month

-10.14%

3 Month

+16.39%

6 Month

+133.19%

YTD

+119.92%

1 Year

+229.13%

5 Year

NA

10 Year

NA

Max

+144.56%

1D

1W

1M

3M

6M

YTD

1Y

5Y

10Y

MAX

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Price Analysis

1 Day

1 Week

1 Month

3 Months

6 Months

1 Year

Low

193.20

190.00

178.50

156.15

80.05

53.80

High

193.20

198.90

220.00

About

Accretion Pharmaceuticals is engaged in the business of manufacturing and marketing of Tablets, Capsules, Oral Liquid, External Preparations (Ointment, Cream, Gel, Lotion, Medicated Shampoo, Mouthwash, Dusting Powder), and Oral Powder Read more

Pharmaceuticals & Drugs

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats

1. Premium insight available after login

2. Sign in to view full SWOT analysis

3. Unlock strengths, weaknesses, opportunities & threats

QVT

Quality

0/100-

Valuation

0/100-

Technical

0/100-

Peer Stocks

1 week

1 month

1 year

Name

SUNPHARMANSE

DIVISLABNSE

TORNTPHARMNSE

ZYDUSLIFENSE

LAURUSLABSNSE

CIPLANSE

DRREDDYNSE

MANKINDNSE

AUROPHARMANSE

LUPINNSE

ACCPL-STNSE

LTP

1W Low

1W High

Market cap (₹)

1746.4-13.6 (-0.77%)

1725.50

1776.60

4,24,466Cr

9023-317 (-3.39%)

8937.50

9431.50

2,46,222Cr

4580-76.9 (-1.65%)

4551.80

4682

1,76,301Cr

1124.7+7.2 (0.64%)

1107.30

1150.90

1,12,818Cr

2036.9+0.3 (0.01%)

2007.80

2069.20

1,10,823Cr

1314.6+13.6 (1.05%)

1300.20

1333.30

1,07,447Cr

1216+19 (1.59%)

1196.90

1250.70

1,03,471Cr

2335-33.5 (-1.41%)

2317.50

2426.80

97,850Cr

1662.9-30.1 (-1.78%)

1654.10

1715

96,836Cr

1953.2-3.3 (-0.17%)

1925.70

1964.90

89,629Cr

193.2+4.25 (2.25%)

190

198.90

215Cr

Accretion Pharmaceuticals Share Price

193.20+0.00 (+0.00%)

+229.13% past 1 Year

Sign in to View

Open a free Demat account in minutes to start investing and screening .

Login Sign Up

Accretion Pharmaceuticals Share Price

193.20+0.00 (+0.00%)

+229.13% past 1 Year

Financial overview

Compounded Sales Growth

10 years-

5 years-

3 years-

Last year56%

Compounded Profit Growth

10 years-

5 years-

3 years-

Last year42%

Stock Price CAGR

10 years-

5 years-

3 years-

1 year229%

Return on Equity

10 years41%

5 years41%

3 years41%

Last year29%

CAGR%

Sales

Profits

Returns

ROE

10Y	5Y	3Y	TTM
-	-	-	56%
-	-	-	42%
-	-	-	229%
41%	41%	41%	29%

Peer Comparison

Symbol

SUNPHARMA

DIVISLAB

TORNTPHARM

ZYDUSLIFE

LAURUSLABS

CIPLA

DRREDDY

MANKIND

AUROPHARMA

LUPIN

ACCPL-ST

Price	M.Cap (₹)	PE Ratio	EPS (₹)	EV/EBITDA	Annual PAT
1,746.4	₹424466 Cr	35.09	12.07	62.82	₹11479 Cr
9,023	₹246222 Cr	84.18	34.04	128.41	₹2568 Cr
4,580	₹176301 Cr	80.83	16.72	97.06	₹2163 Cr
1,124.7	₹112818 Cr	25	9.42	62.53	₹5040 Cr
2,036.9	₹110823 Cr	101.36	6.8	29.25	₹889 Cr
1,314.6	₹107447 Cr	31.88	9.77	57.87	₹3879 Cr
1,216	₹103471 Cr	32.11	5.32	63.99	₹4196 Cr
2,335	₹97850 Cr	47.9	13.75	71.08	₹1913 Cr
1,662.9	₹96836 Cr	26.08	17.95	96.84	₹3505 Cr
1,953.2	₹89629 Cr	16.21	30.95	154.35	₹5333 Cr
193.2	₹215 Cr	22.21	—	9.79	₹10 Cr

Profit & Loss

Consolidated

Standalone

Quarterly

Yearly

₹

%

Balance Sheet

Consolidated

Standalone

₹

%

Name

Equity And Liabilities

Share Capital

Total Reserves

Reserve excluding Revaluation Reserve

Shareholder's Funds

Secured Loans

Unsecured Loans

Deferred Tax Assets / Liabilities

Total Non-Current Liabilities

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Current Liabilities

Total Liabilities

Total Debt

Assets

Gross Block

Less Accumulated Depreciation

Net Block

Capital Work in Progress

Long Term Loans & Advances

Other Non Current Assets

Total Non-Current Assets

Current Assets Loans & Advances

Inventories

Sundry Debtors

Cash and Bank

Other Current Assets

Short Term Loans and Advances

Total Current Assets

Net Current Assets (Including Current Investments)

Miscellaneous Expenses not written off

Total Assets

Book Value

Adjusted Book Value

Mar 2026	Mar 2025	Mar 2024
—	—	—
₹11 Cr	₹8 Cr	₹4 Cr
₹44 Cr	₹7 Cr	₹1 Cr
₹44 Cr	₹7 Cr	₹1 Cr
₹55 Cr	₹15 Cr	₹5 Cr
₹0	₹23 L	₹1 Cr
₹86 L	₹94 L	₹6 Cr
₹27 L	₹19 L	₹14,000
₹1 Cr	₹1 Cr	₹7 Cr
—	—	—
₹6 Cr	₹8 Cr	₹7 Cr
₹3 Cr	₹4 Cr	₹2 Cr
₹9 Cr	₹9 Cr	₹4 Cr
₹4 Cr	₹3 Cr	₹2 Cr
₹21 Cr	₹23 Cr	₹15 Cr
₹77 Cr	₹40 Cr	₹27 Cr
₹12 Cr	₹14 Cr	₹13 Cr
—	—	—
₹15 Cr	₹7 Cr	₹5 Cr
₹2 Cr	₹100 L	₹22 L
₹13 Cr	₹6 Cr	₹5 Cr
₹20 L	₹0	₹0
₹31 L	₹23 L	₹0
₹0	₹66,000	₹13 L
₹14 Cr	₹6 Cr	₹5 Cr
—	—	—
₹28 Cr	₹21 Cr	₹14 Cr
₹22 Cr	₹12 Cr	₹6 Cr
₹4 Cr	₹5 L	₹9 L
₹2 L	₹2 L	₹6 L
₹6 Cr	₹1 Cr	₹2 Cr
₹60 Cr	₹33 Cr	₹22 Cr
₹40 Cr	₹10 Cr	₹7 Cr
₹3 Cr	₹10 L	₹0
₹77 Cr	₹40 Cr	₹27 Cr
₹47	₹19	₹14
₹47	₹19	₹7

Cash Flow

Consolidated

Standalone

₹

%

Name

Profit Before Tax

Adjustment

Changes In working Capital

Cash Flow after changes in Working Capital

Cash Flow from Operating Activities

Cash Flow from Investing Activities

Cash Flow from Financing Activitie

Net Cash Inflow / Outflow

Opening Cash & Cash Equivalents

Closing Cash & Cash Equivalent

Mar 2026	Mar 2025	Mar 2024
₹13 Cr	₹10 Cr	₹2 Cr
₹2 Cr	₹2 Cr	₹62 L
-₹26 Cr	-₹10 Cr	-₹15 Cr
-₹11 Cr	₹2 Cr	-₹12 Cr
-₹15 Cr	-₹62 L	-₹12 Cr
-₹9 Cr	-₹2 Cr	-₹5 Cr
₹27 Cr	₹2 Cr	₹17 Cr
₹4 Cr	-₹4 L	₹9 L
₹5 L	₹9 L	₹0
₹4 Cr	₹5 L	₹9 L

Fundamental Ratios

Consolidated

Standalone

No results found

Accretion Pharmaceuticals Share Price

193.20+0.00 (+0.00%)

+229.13% past 1 Year

02 Jan 25+9D

Bid/Ask

Price

Greeks

Stradle

Custom

CALLS

Qty/ots

PUTS

Sign in to View

Open a free Demat account in minutes to start investing and screening .

Login Sign Up

Accretion Pharmaceuticals Share Price

193.20+0.00 (+0.00%)

+229.13% past 1 Year

Technical meters

Oscillators

Strong SellSellNeutralBuyStrong Buy

Bullish signals: 2

Bearish signals: 2 out of 9 oscillators

RSI

46.18Neutral

STOCH %K

35.42Neutral

MACD Level(12,26)

-3.02Sell

Ultimate Oscillator

55.07Buy

Aroon Oscillator

82.00Buy

BOP

0.00Neutral

CCI

-53.67Neutral

Williams %R

-64.58Neutral

Momentum

-11.75Sell

Moving averages

Strong SellSellNeutralBuyStrong Buy

Bullish signals: 4

Bearish signals: 5 out of 9 moving averages

EMA 9

193.25Sell

SMA 9

191.33Buy

EMA 21

197.46Sell

SMA 21

201.62Sell

EMA 50

192.69Buy

SMA 50

198.93Sell

EMA 200

142.84Buy

SMA 200

127.28Buy

WMA 20

196.41Sell

Pivot

Classic

Resistance 5

217.90

Resistance 4

212.20

Resistance 3

206.50

Resistance 2

200.80

Resistance 1

197.00

Pivot

195.10

Support 1

191.30

Support 2

189.40

Support 3

183.70

Support 4

178.00

Support 5

172.30

High & lows

1 Day

1 Week

1 Month

3 Months

6 Months

Year to Date

1 Year

3 Years

5 Years

10 Years

All Time

Low

193.20

190.00

178.50

156.15

80.05

62.00

53.80

High

193.20

198.90

220.00

Returns

+0.00

+4.25

-21.80

+27.20

+110.35

+105.35

+134.50

—

+114.20

Beta

—

Std. deviation %

—

Sign in to view

Open a free Demat account in minutes to start investing and screening .

Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025
73.52%	73.52%	73.52%	73.52%	73.51%
0.00%	0.00%	0.00%	1.16%	2.22%
2.76%	0.00%	0.00%	0.00%	0.09%
0.00%	0.00%	0.00%	0.00%	0.00%
23.72%	26.48%	26.48%	25.32%	24.18%

Deal Date	Action	Deal Value	Deal Price	Qty Traded	Deal Type	%Stake Traded	Exchange
29 Apr 2026	Purchase	68.95 L	₹102.60	67.20 K	Bulk	0.604534	NSE
18 Nov 2025	Purchase	74.64 L	₹76.79	97.20 K	Bulk	0.874415	NSE
21 May 2025	Sell	1.16 Cr	₹82.95	1.40 L	Bulk	1.263044	NSE

Accretion Pharmaceuticals Share Price

193.20+0.00 (+0.00%)

+229.13% past 1 Year

Accretion Pharmaceuticals is engaged in the business of manufacturing and marketing of Tablets, Capsules, Oral Liquid, External Preparations (Ointment, Cream, Gel, Lotion, Medicated Shampoo, Mouthwash, Dusting Powder), and Oral Powder

Corporate Actions

Date

Type

Details

No data available.

Company details

Registered office

29 Xcelon Ind Park 1 B/h, Intas Pharmaceuticals Vasna Chacharvadi, Sanand Ahmedabad Gujarat PIN: 382213 Tel No: 9714882929 Fax No: NULL Email: [email protected] / [email protected] Internet: www.accretionpharma.com

Registrars

Karvy Selenium Tower B, Plot 31-32Gachibowli,Financial District, NanakramgudaHyderabad – 500032Tel. No. 040 67161500Fax. No. 040 23001153E-mail: [email protected]: www.karvy.comToll Free No. of exclusive Call Centre:1-800-345001 Karvy Selenium Tower B, Plot 31-32 Gachibowli,Financial District Nanakramguda PIN: Tel No: 040 - 67162222/18003094001 Fax No: NULL Email: [email protected] Internet: www.kfintech.com

Management

Harshad Nanubhai Rathod, Chairman & Chief Financial Officer

Vivek Ashok Kumar Patel, Managing Director

Hardik Mukundbhai Prajapati, Executive Director

Grishma Ajayrao Shewale, Non Executive Independent Director

Chand Rameshbhai Kanabar, Non Executive Independent Director

Nishtha Harivanshi Pamnani, Non Executive Independent Director

Mayur Popatlal Sojitra, Promoter & Non-Executive Director

Roshni Dharmendrabhai Shah, Company Secretary & Compliance Officer

Details

BSE 0

NSE ACCPL

ISIN INE0T8T01010

Accretion Pharmaceuticals Share Price

193.20+0.00 (+0.00%)

+229.13% past 1 Year

Corporate filings & documents

Announcements

No announcements found

Annual reports

FY 2024-25

FY 2023-24

Concalls & investor presentations

May 2026

ConcallPresentation

Accretion Pharmaceuticals Share Price

193.20+0.00 (+0.00%)

+229.13% past 1 Year

News

No news found

Accretion Pharmaceuticals Share Price

Price Analysis

Share Price Live Stats

Share Market Cap & Key Ratios Overview

About

Stock Analysis (SWOT)

QVT

Peer Stocks

Accretion Pharmaceuticals Share Price

Accretion Pharmaceuticals Share Price

Financial overview

Compounded Sales Growth

Compounded Profit Growth

Stock Price CAGR

Return on Equity

Peer Comparison

Profit & Loss

Balance Sheet

Cash Flow

Fundamental Ratios

Accretion Pharmaceuticals Share Price

Accretion Pharmaceuticals Share Price

Oscillators

Moving averages

Accretion Pharmaceuticals Share Price

Shareholding summary

Shareholding Pattern

Bulk & block deals

Insider trading & SAST

Accretion Pharmaceuticals Share Price

Corporate Actions

Company details

Accretion Pharmaceuticals Share Price

Corporate filings & documents

Announcements

Annual reports

Concalls & investor presentations

Accretion Pharmaceuticals Share Price

News

Accretion Pharmaceuticals Ltd Share Price Today

Accretion Pharmaceuticals Quick Links

Other Stocks

Calculators

Brokerage Calculator

Stock Average Calculator

MTF Calculator

Margin Calculator

Span Margin Calculator